Covered recipient · General Payments record
SOERIA D SANDERFORD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2023
$1,662.55
- Reported across 107 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $258.56 | 18 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $192.00 | 14 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.83 | 1 |
| Exact Sciences Corporation | $17.16 | 1 |
| Lilly USA, LLC | $15.68 | 1 |
| Kowa Pharmaceuticals America, Inc. | $12.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.66 | 01/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009686775 | CMS |
| ABBVIE INC. | $10.87 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009686779 | CMS |
| ABBVIE INC. | $16.36 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009686785 | CMS |
| ABBVIE INC. | $21.88 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009686789 | CMS |
| ABBVIE INC. | $6.52 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009686793 | CMS |
| ABBVIE INC. | $9.73 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009686797 | CMS |
| ABBVIE INC. | $9.72 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009686803 | CMS |
| ABBVIE INC. | $11.25 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009686807 | CMS |
| ABBVIE INC. | $7.30 | 04/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009686811 | CMS |
| ABBVIE INC. | $7.28 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009686817 | CMS |
| ABBVIE INC. | $13.74 | 05/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009686821 | CMS |
| ABBVIE INC. | $11.46 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009686827 | CMS |
| ABBVIE INC. | $12.77 | 07/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009686831 | CMS |
| ABBVIE INC. | $20.46 | 08/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009686836 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.83 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005583061 | CMS |
| Exact Sciences Corporation | $17.16 | 11/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026805369 | CMS |
| Kowa Pharmaceuticals America, Inc. | $12.89 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003928491 | CMS |
| Lilly USA, LLC | $15.68 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033719799 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.